3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Breast Neoplasms
4
Oropharyngeal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Kidney Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Thyroid Nodule
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Salivary Gland Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Polycystic Ovary Syndrome
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Cervical Cancer
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Interventions
Oxaliplatin
8
Fluorouracil
8
pembrolizumab
7
Paclitaxel
6
Trastuzumab
5
Leucovorin
5
Capecitabine
5
Specimen Handling
4
Radiation
4
Cisplatin
4
Carboplatin
4
tislelizumab
3
patritumab deruxtecan
3
Taxes
3
Radiotherapy
3
Nivolumab
3
ulixertinib
2
trastuzumab deruxtecan
2
trastuzumab biosimilar HLX02
2
durvalumab
2
Surgical Procedures, Operative
2
Ramucirumab
2
Pemetrexed
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Immunotherapy
2
Exercise
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Surveys and Questionnaires
×
30 days
×
Clear all
No trials found.